About HumaSkan
We are a medical device manufacturer dedicated to creating high-quality, innovative solutions for healthcare professionals and patients.
Manufacturing
Development
Licence
Patent
Design
Our Story
HUMASKAN LTD was formed to capitalize on the opportunities for non-invasive medical home testing, which has, following the Covid epidemic, become a dynamic growth area in patient care.
The company aims to become a major contributor to providing unique, novel and cutting-edge technologies in non-invasive medical testing and monitoring.
Income will be derived from licensing and distribution agreements both by country and by region, proving royalty payments and licence fees.
Combing in house expertise with external research groups, the company plans over the next 12 months to develop its product portfolio and expand on the patents already filed for some of its existing product portfolio.
The company are presently not revenue generating, focusing on product development patenting and regulatory approval, for which patent applications gave been made and the company’s WoundSkan product is registered with the FDA in the USA, in Europe under the CE mark, and in the United Kingdom with the UKCE mark. Humaskan’s Lateral Flow Tests will commence regulatory trials early in 2026 in the USA under FDA regulations for a Class II medical device.